Bymaster Frank P, Felder Christian C, Tzavara Eleni, Nomikos George G, Calligaro David O, Mckinzie David L
Neuroscience Research Division, Lilly Research Laboratories, Lilly Corporate Center, Indianapolis, IN 46285-0510, USA.
Prog Neuropsychopharmacol Biol Psychiatry. 2003 Oct;27(7):1125-43. doi: 10.1016/j.pnpbp.2003.09.008.
The interactions of the atypical antipsychotic drugs (APD) clozapine, olanzapine, risperidone, quetiapine and ziprasidone with muscarinic receptors were reviewed. Only clozapine and olanzapine have marked affinity for muscarinic receptors in radioligand binding studies; however, the affinity of these compounds is considerably lower than classical muscarinic antagonists. Although functional assays in cell lines transfected with muscarinic receptors suggest that olanzapine and clozapine have weak partial agonist activity at muscarinic receptors, particularly M4 receptors, studies in vitro and in vivo indicate that the compounds function as antagonists. In animal studies and in humans, clozapine has pronounced antimuscarinic effects whereas olanzapine has weak antimuscarinic effects. However, olanzapine significantly occupies central muscarinic receptors in humans. Overall, the role of muscarinic receptors in the antipsychotic effects of clozapine and olanzapine is controversial and complex.
对非典型抗精神病药物(APD)氯氮平、奥氮平、利培酮、喹硫平和齐拉西酮与毒蕈碱受体的相互作用进行了综述。在放射性配体结合研究中,只有氯氮平和奥氮平对毒蕈碱受体具有显著亲和力;然而,这些化合物的亲和力远低于经典的毒蕈碱拮抗剂。尽管在用毒蕈碱受体转染的细胞系中进行的功能测定表明,奥氮平和氯氮平在毒蕈碱受体,特别是M4受体上具有较弱的部分激动剂活性,但体外和体内研究表明,这些化合物起拮抗剂的作用。在动物研究和人体研究中,氯氮平具有明显的抗毒蕈碱作用,而奥氮平具有较弱的抗毒蕈碱作用。然而,奥氮平在人体中显著占据中枢毒蕈碱受体。总体而言,毒蕈碱受体在氯氮平和奥氮平抗精神病作用中的作用存在争议且复杂。